0
0
0
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
12/19/2024, 9:05 AM
Summary of Bill HR 7090
Bill 118 hr 7090, also known as the "Clinical Trial Participant Compensation Exclusion Act," aims to amend the Internal Revenue Code of 1986 to exclude certain compensation received by individuals participating in clinical trials from their gross income.
The bill recognizes the important role that clinical trial participants play in advancing medical research and innovation. By excluding compensation received for participating in these trials from gross income, the bill seeks to incentivize more individuals to participate in clinical trials, ultimately leading to the development of new and improved medical treatments and therapies.
Under the provisions of the bill, compensation received by clinical trial participants for their time, travel expenses, and other related costs would not be subject to federal income tax. This would provide much-needed financial relief to individuals who volunteer for these trials and help remove a potential barrier to participation. Overall, the Clinical Trial Participant Compensation Exclusion Act aims to support and encourage participation in clinical trials, ultimately benefiting both individuals and the broader medical community.
The bill recognizes the important role that clinical trial participants play in advancing medical research and innovation. By excluding compensation received for participating in these trials from gross income, the bill seeks to incentivize more individuals to participate in clinical trials, ultimately leading to the development of new and improved medical treatments and therapies.
Under the provisions of the bill, compensation received by clinical trial participants for their time, travel expenses, and other related costs would not be subject to federal income tax. This would provide much-needed financial relief to individuals who volunteer for these trials and help remove a potential barrier to participation. Overall, the Clinical Trial Participant Compensation Exclusion Act aims to support and encourage participation in clinical trials, ultimately benefiting both individuals and the broader medical community.
Congressional Summary of HR 7090
This bill excludes from gross income, for income tax purposes, amounts received as payment or reimbursement for participation in an approved clinical trial (i.e., a trial conducted for the prevention, detection, or treatment of cancer or other life-threatening disease or condition). This includes amounts paid or reimbursed for meals, lodging, or travel expenses.
Read the Full Bill
Current Status of Bill HR 7090
Bill HR 7090 is currently in the status of Bill Introduced since January 25, 2024. Bill HR 7090 was introduced during Congress 118 and was introduced to the House on January 25, 2024. Bill HR 7090's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 7090
Total Number of Sponsors
2Democrat Sponsors
0Republican Sponsors
2Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
1Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 7090
Primary Policy Focus
TaxationAlternate Title(s) of Bill HR 7090
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Comments
Sponsors and Cosponsors of HR 7090
Latest Bills
Veterinary Services to Improve Public Health in Rural Communities Act
Bill HR 8473May 4, 2026
Hemp Safety Enforcement Act
Bill S 4315May 4, 2026
Recognizing the disenfranchisement of District of Columbia residents, calling for statehood for the District of Columbia through the enactment of the Washington, D.C. Admission Act, and expressing support for the designation of May 1, 2026, as "D.C. Statehood Day".
Bill HRES 1244May 4, 2026
Stopping Fraudulent Payments Act
Bill HR 8464May 4, 2026
Supporting the recognition of April 2026 as "National County Government Month" to honor the county government workforce, educate residents about local programs and services, and celebrate the county government role in the intergovernmental partnership.
Bill HRES 1213May 4, 2026
Securing America’s Drug Supply from Communist China Act
Bill S 4327May 4, 2026
ENDS Chinese Vapes Act of 2026
Bill S 4303May 4, 2026
Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community.
Bill HRES 1251May 4, 2026
Expressing the sense of the House of Representatives in support of the integration of Kosovo into the North Atlantic Treaty Organization.
Bill HRES 1246May 4, 2026
Expressing support for United States forces to remain as a part of the Kosovo Force.
Bill HRES 1250May 4, 2026
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Bill HR 7418March 18, 2024